Q4 2013 Sucampo Pharmaceuticals, Inc. Earnings Release – After Market Close
moreView todays social media effects on SCMPView the latest stocks trending across Twitter. Click to view dashboardSee who Sucampo is hiring next, click here to view […]
SCMP
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
moreView todays social media effects on SCMPView the latest stocks trending across Twitter. Click to view dashboardSee who Sucampo is hiring next, click here to view […]
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K/A, Regulation FD Disclosure, Financial Statements and Exhibits
moreView todays social media effects on SCMPView the latest stocks trending across Twitter. Click to view dashboardSee who Sucampo is hiring next, click here to view […]
Sucampo Pharmaceuticals Announces Fourth Quarter and Full Year 2013 Results and Operating Highlights Teleconference and Webcast
[GlobeNewswire] – BETHESDA, Md. — Sucampo Pharmaceuticals, Inc. (Sucampo), a global biopharmaceutical company, today announced that it will host a webcast and teleconference with senior management to discuss … moreView todays social media effects on SCMPView the latest stocks trending across Twitter. Click to view dashboardSee who Sucampo is hiring next, click here to view […]
Sucampo Announces Japanese Government Funding for Unoprostone Isopropyl Development in Retinitis Pigmentosa
[Business Wire] – BETHESDA, Md.–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that the Japan Science and Technology Agency (JST) has adopted unoprostone isopropyl ophthalmic solution .15% … moreView todays social media effects on SCMPView the latest stocks trending across Twitter. Click to view dashboardSee who Sucampo is hiring next, click here to view […]
Sucampo Receives $15 Million Milestone Payment from Abbott on First Sale of AMITIZA® (lubiprostone) in Japan
[Business Wire] – BETHESDA, Md. & TOKYO–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced that its subsidiary, Sucampo AG, has received a $15 million milestone payment from Abbott’s (NYSE: … moreView todays social media effects on SCMPView the latest stocks trending across Twitter. Click to view dashboardSee who Sucampo is hiring next, click here to view […]
Sucampo and Abbott Announce Launch of AMITIZA in Japan
[Business Wire] – BETHESDA, Md.–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Abbott (NYSE: ABT) today announced the availability of AMITIZA ® (lubiprostone) in Japan, a prescription medicine … moreView todays social media effects on SCMPView the latest stocks trending across Twitter. Click to view dashboard […]
